Tag Archives: biobreakfast

BioBreakfast – Innovation Challenges in Healthcare – 19 Feb 2019

BioMelbourne Network BioBreakfast logo

BioBreakfast:  Innovation Challenges in Healthcare – Tuesday 19th February

BioMelbourne Network BioBreakfast logo
Shaping the Future of Health
BioBreakfast Series
Tuesday, 19 February 2019
Innovation Challenges in Healthcare

Guest speakers: Sue Shilbury, Chief Executive Officer, Austin Health
Craig Bosworth, Group Director, Strategy & Marketing, Cabrini Health

Announcing the BioMelbourne Network 2019 “Shaping the Future of Health” BioBreakfast series, sponsored by the Victorian State Government (DJPR), to lead the conversation in aligning industry growth and economic development with future healthcare needs.

This series of quarterly events brings together players across the health value chain, from industry, research, health, finance and government to explore ways in which Victoria can foster an innovation driven, technology enabled healthcare system. 
Join us for our first event in February 2019 “Innovation Challenges in Healthcare” with hospital executives Sue Shilbury, Chief Executive Officer, Austin Health and Craig Bosworth, Group Director, Strategy & Marketing, Cabrini Health. Our speakers will share their views on innovation challenges, insights into future service delivery aspirations, market players and sector trends, and explore ways to bring about change in the healthcare system to address unmet patient needs.  

When Tuesday, 19 February 2019
Time  7:20 am – Registration 7:30 am – Networking breakfast  8:00 am – Presentations and discussion  9:00 am – Ends
Where The Cube, ACMI, Federation Square, Melbourne
Cost BioMelbourne Network Members: $65;
Non-members: $130 (prices include GST)

Check if your organisation is a member      


Sue Shilbury, Chief Executive Officer, Austin Health
Sue Shilbury joined Austin Health as CEO in early 2017, following a three-decade career in the New South Wales (NSW) public health sector. Sue was General Manager of North Shore Ryde Health Service where she oversaw the delivery of NSW Health’s largest capital works program, the $1.3 billion redevelopment of Royal North Shore Hospital. Sue has also held roles as General Manager of the Central Hospital Network (South Eastern Sydney and Illawarra Health District), Director of the Division of Critical Care and Surgery at St George Hospital, and Director of Clinical Services at the Royal Hospital for Women.      

Craig Bosworth, Group Director, Strategy & Marketing, Cabrini Health
Craig joined Cabrini in July 2018. His experience covers a range of sectors across primary and tertiary healthcare, compensable and private health insurance, aged care and the National Disability Insurance Scheme. Having graduated as a physiotherapist, he became a Director of Olympic Park Sport Medicine Centre before working for a number of organisations including TAC, Worksafe, Medibank Private, Healthways Australia and Healthdirect Australia. He was Chief of Staff to the Federal Minister for Health, Aged Care and Sport from 2015 to 2016. Craig holds an MBA from Melbourne Business School, and has studied at Wharton (finance), Stanford (strategy) and Monash (health economics) universities. He is a Graduate of the Australian Institute of Company Directors. He is a past Director of Comcare, Multicultural Arts Victoria and the NSW Ministerial Advisory Board for Preventative Health.

This article appears courtesy of our proud precinct partner, BioMelbourne Network

BioBreakfast – Transformation in Pharma Manufacturing for Clinical Trials – 10 December

BioMelbourne Network BioBreakfast logo

As part of our ongoing advanced manufacturing series this BioBreakfast will be looking at topics around issues relating to manufacturing for clinical trials and challenges in phase II trials.

With guests:

Dr Jane Ryan – Consultant for Stakeholder Engagement, CSIRO
Craig Rogers – SVP of Asia Pacific, PCI Clinical Services
Dr Christian Behrenbruch – Chief Executive Officer, Telix Pharmaceuticals Limited
Jo Sherriff – Senior GMP Consultant, SeerPharma

Jane Ryan, representing CSIRO, will be speaking at the event on the Advanced Biotechnology Manufacturing Platform (ABMP) and their vision for addressing the unmet need in scaling-up manufacturing for clinical trials. The proposed manufacturing facility, ABMP, will enable process development and production of clinical-grade biologicals at the pilot scale to support clinical translation.

Craig Rogers, Senior Vice President for PCI Asia Pacific will be joining Jane in presenting and then both speakers will be taking part in a panel discussion together with Christian Behrenbruch, Chief Executive Officer, Telix Pharmaceuticals Limited and facilitated by Jo Sherriff, Senior GMP Consultant, SeerPharma. Areas for discussion include innovation strategies improving streamline efficiencies in increased production processes with increasingly complex manufacturing environments.

When: Monday 10 December 2018

Where: The Cube, ACMI, Federation Square, Melbourne

Cost: BioMelbourne Network Members: $65; Non-members: $130 (prices include GST)

Check if your organisation is a member

Time
7:20 am – Registration
7:30 am – Networking breakfast
8:00 am – Presentations and discussion
9:00 am – Close

Book now

About our guest speaker/s

Female doctor with medium length dark hair smiles at the camera

Dr Jane Ryan
Consultant for Stakeholder Engagement, CSIRO

Jane has over 30 years of international experience in the pharmaceutical and biotechnology industries where she has held executive roles in management of research and development programs as well as business development and alliance management. Jane has worked in Australia, the US and UK with companies including Peptech, Roche, Cambridge Antibody Technology and Biota Holdings. Throughout her career, she has led many successful fundraising campaigns and licensing initiatives including the awarding of a $230m US Government contract.

Jane currently chairs the Advisory Board at the ithree Institute at the University of Technology Sydney (UTS) which studies how microbes grow, live, adapt and survive. She is also Part-time Vice President of Research and Development at Reef Pharmaceuticals and advisor to Opal Pharmaceuticals. Jane was previously a Board Member of Diabetes Victoria, TechInSA, Diabetes Vaccine Development Centre, and veski. Jane is assisting CSIRO with its GMP protein manufacture initiative.

 

Craig RogersMale pharmacist wearing glasses and a red tie smiles at the camera.

SVP of Asia Pacific, PCI Clinical Services

Craig Rogers is a registered pharmacist, toxicologist and lawyer. He has more than 20 years of experience working within the pharmaceutical industry with a specific focus on manufacture of investigational product for early phase clinical trials and regulatory affairs. Craig established PPP a TGA licensed cGMP manufacturing facility in 2008, based on his gap analysis of the services available in the local market for finished product manufacture of investigational products. He sold the business to the US-based PCI Pharma Services in March 2018.

 

Joining the speakers on the panel

Dr Christian BehrenbruchBlack and white photo of male doctor smiling at the camera

Chief Executive Officer, Telix Pharmaceuticals Limited

Chris Behrenbruch has 20 years of healthcare entrepreneurship and executive leadership experience. He has previously served in a CEO or Executive Director capacity at Mirada Solutions, CTI Molecular Imaging (now Siemens Healthcare), Fibron Technologies and ImaginAb, Inc. He is a former Director of Momentum Biosciences LLC, Siemens Molecular Imaging Ltd, Radius Health Ltd (now Adaptix) and was the former Chairman of Cell Therapies P/L (a partnership with the Peter MacCallum Cancer Centre). Chris is currently a director of Factor Therapeutics (ASX:FTT) and Amplia Therapeutics P/L. He is

Chairman of the Monash Engineering and IT Foundation Board and is an Adjunct Professor at Monash University. Chris holds a D.Phil (PhD) in biomedical engineering from the University of Oxford, an executive MBA jointly awarded from New York University, HEC Paris and the London School of Economics (TRIUM Program) and a Juris Doctor (Law) from the University of Melbourne.

 

Facilitated by

Jo Sherriff           Female Chemist wearing glasses smiles at the camera

Senior GMP Consultant, SeerPharma

Jo is an experienced senior compliance engineer and senior consultant, with 20 years of experience within the pharmaceutical and life science industries. She is not only a qualified Chemical Engineer but also a specialist in development and execution of GMP validation documentation; GMP Design Reviews; and development of Quality Systems. She also has extensive experience with non-GMP facility compliance, TGA, FDA, DAWR (Biosecurity), OGTR, ARPANSA, SSBA, and Pharmacy Board of Australia, SHPA, PRASA compliance.

Jo is an experienced presenter of Validation Workshops and GMP Training, and conducts Quality Assurance Audits.